Disease X: accelerating the development of medical countermeasures for the next pandemic
- 17 March 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 20 (5), e108-e115
- https://doi.org/10.1016/s1473-3099(20)30123-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Understanding Ebola: the 2014 epidemicGlobalization and Health, 2016
- Product Development Under FDA’s Animal Rule: Understanding FDA’s Expectations and Potential Implications for Traditional Development ProgramsTherapeutic Innovation & Regulatory Science, 2016
- Spillover and pandemic properties of zoonotic viruses with high host plasticityScientific Reports, 2015
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsMolecular Therapy, 2015
- Capacity building efforts and perceptions for wildlife surveillance to detect zoonotic pathogens: comparing stakeholder perspectivesBMC Public Health, 2014
- RNA Viruses: A Case Study of the Biology of Emerging Infectious DiseasesMicrobiology Spectrum, 2013
- Prediction and prevention of the next pandemic zoonosisThe Lancet, 2012
- Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1PLoS Medicine, 2010
- Temporal trends in the discovery of human virusesProceedings. Biological sciences, 2008
- Global trends in emerging infectious diseasesNature, 2008